Find policies, billing codes, payers, states, and providers
CPT 17263: Destruction of Malignant Skin Lesion, 2.1–3.0 cm
CPT code 17263 represents the destruction of a malignant cutaneous lesion on the trunk, arms, or legs that is 2.1 cm to 3.0 cm in diameter, using methods such as chemosurgery, cryosurgery, electrosurgery, or other destructive techniques. This procedural code standardizes reporting for medium-sized malignant skin lesion destruction and is relevant nationally for clinicians, billing teams, and payers managing dermatologic oncology services. Key payers in the review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise clinical and billing overview, typical sites of service, and the service type associated with CPT code 17263. The publication outlines common payer coverage considerations, coding context, and benchmarking elements relevant to outpatient dermatology and ambulatory surgical settings. It also highlights where data was not provided in the input so readers can identify gaps for local policy or payer contract review. The content is intended to inform coding accuracy, revenue cycle workflows, and administrative policy alignment across national payers without offering clinical recommendations.
Customize your policy alerts
Sign up for cpt 17263 policy alerts
Get alerted when payer policies referencing 17263 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 17263 describes destruction of a malignant lesion located on the trunk, arms, or legs using techniques such as chemosurgery, cryosurgery, electrosurgery, or other destructive methods. The code applies when the target lesion measures 2.1 cm to 3.0 cm in diameter.
Service type: Destruction of malignant cutaneous lesion (surgical/dermatologic procedure)
Typical site of service: Outpatient dermatology clinic, ambulatory surgical center, or physician office
Data not available in the input.